Biochemical and clinical characteristics of creatine deficiency syndromes
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Creatine deficiency syndromes are a newly described group of inborn errors of creatine synthesis (arginine:glycine amidinotransferase (AGAT) deficiency and guanidinoacetate methyltransferase (GAMT) deficiency) and of creatine transport (creatine transporter (CRTR) deficiency). The common clinical feature of creatine deficiency syndromes is mental retardation and epilepsy suggesting main involvement of cerebral gray matter. The typical biochemical abnormality of creatine deficiency syndromes is cerebral creatine deficiency, which is demonstrated by in vivo proton magnetic resonance spectroscopy. Measurement of guanidinoacetate in body fluids may discriminate between the GAMT (high concentration), AGAT (low concentration) and CRTR (normal concentration) deficiencies. Further biochemical characteristics include changes in creatine and creatinine concentrations in body fluids. GAMT and AGAT deficiency are treatable by oral creatine supplementation, while patients with CRTR deficiency do not respond to this type of treatment. The creatine deficiency syndromes are underdiagnosed, so their possibility should be considered in all children affected by unexplained mental retardation, seizures and speech delay.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This class of syndromes results in a reduction or inability to endogenously synthesize creatine leading low levels of creatine and phosphocreatine in the muscle and brain.”
From Safety of Creatine Supplementation in Active Adolescents and Youth: A Brief Review (2018) · cites this paper as [92]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Some individuals have been found to have creatine synthesis deficiencies due to inborn errors in AGAT, GMAT and/or creatine transporter (CRTR) deficiencies and therefore must depend on dietary creatine intake in order to maintain normal muscle and brain concentrations of PCr and Cr”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As a result, they often have clinical manifestations of muscle myopathies, gyrate atrophy, movement disorders, speech delay, autism, mental retardation, epilepsy, and/or developmental problems [13, 17, 145].”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The physical presentation of this scenario includes muscle myopathies, gyrate atrophy, movement disorders, speech delay, autism, mental development challenges, epilepsy, and other developmental problems (91–93)”
From Safety of Creatine Supplementation in Active Adolescents and Youth: A Brief Review (2018) · cites this paper as [92]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Individuals with creatine synthesis deficiencies have low levels of creatine and PCr in the muscle and the brain.”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [17]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Greenhaff, P. L., Casey, A., Short, A. H., Harris, R., Soderlund, K., & Hultman, E. (1993) · Clinical Science · doi:10.1042/cs0840565 · Cited by 460
Creatine deficiency in the brain: A new, treatable inborn error of metabolism
Stöckler, S., Holzbach, U., Hanefeld, F., Marquardt, I., Helms, G., Requart, M., Hänicke, W., & Frahm, J. (1994) · Pediatric Research · doi:10.1203/00006450-199409000-00023 · Cited by 417
X-Linked Creatine-Transporter Gene (SLC6A8) Defect: A New Creatine-Deficiency Syndrome
Salomons, G. S., van Dooren, S. J. M., Verhoeven, N. M., Cecil, K. M., Ball, W. S., Degrauw, T. J., & Jakobs, C. (2001) · The American Journal of Human Genetics · doi:10.1086/320595 · Cited by 396
Physician’s Guide to the Laboratory Diagnosis of Metabolic Diseases
(2003) · Springer eBooks · doi:10.1007/978-3-642-55878-8 · Cited by 271
Stöckler, S., Hanefeld, F., & Frahm, J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)04116-5 · Cited by 240
Guanidinoacetate methyltransferase deficiency: the first inborn error of creatine metabolism in man.
Stöckler, S., Isbrandt, D., Hanefeld, F. A., Schmidt, B., & FIGURA, K. V. (1996) · PubMed · Cited by 219
Schulze, A., Hess, T., Wevers, R., Mayatepek, E., Bachert, P., Marescau, B., Knopp, M. V., De Deyn, P. P., Bremer, H. J., & Rating, D. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70075-1 · Cited by 170
Reversible brain creatine deficiency in two sisters with normal blood creatine level
Bianchi, M. C., Tosetti, M., Fornai, F., Grazia Alessandri', M., Cipriani, P., De Vito, G., & Canapicchi, R. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4<511::aid-ana15>3.0.co;2-n · Cited by 148
Clinical characteristics and diagnostic clues in inborn errors of creatine metabolism
Stromberger, C., Bodamer, O. A., & Stöckler‐Ipsiroglu, S. (2003) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1024453704800 · Cited by 130
Self-citationStöckler, S., Marescau, B., Deyn, P. R. D., Trijbels, J. M. F., & Hanefeld, F. A. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90215-8 · Cited by 120
Lack of creatine in muscle and brain in an adult with GAMT deficiency
Schulze, A., Bachert, P., Schlemmer, H., Harting, I., Polster, T., Salomons, G. S., Verhoeven, N. M., Jakobs, C., Fowler, B., Hoffmann, G. F., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10455 · Cited by 119
Hahn, K. A., Salomons, G. S., Tackels, D., Wood, T. C., Taylor, H. A., Schroer, R. J., Lubs, H. A., Jakobs, C., Olson, R. L., Holden, K. R., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/340092 · Cited by 117
Guanidinoacetate methyltransferase deficiency: New clinical features
Ganesan, V., Johnson, A., Connelly, A., Eckhardt, S., & Surtees, R. A. H. (1997) · Pediatric Neurology · doi:10.1016/s0887-8994(97)00083-0 · Cited by 108
Battini, R., Leuzzi, V., Carducci, C., Tosetti, M., Bianchi, M. C., Item, C. B., Stöckler‐Ipsiroglu, S., & Cioni, G. (2002) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(02)00175-0 · Cited by 105
Self-citationX‐linked creatine deficiency syndrome: A novel mutation in creatine transporter gene SLC6A8
Bizzi, A., Bugiani, M., Salomons, G. S., Hunneman, D. H., Moroni, I., Estienne, M., Danesi, U., Jakobs, C., & Uziel, G. (2002) · Annals of Neurology · doi:10.1002/ana.10246 · Cited by 88
Fink, G. R., Driver, J., Rorden, C., Baldeweg, T., & Dolan, R. J. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4<440::aid-ana6>3.0.co;2-e · Cited by 82
Ilas, J., Mühl, A., & Stöckler‐Ipsiroglu, S. (2000) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00182-5 · Cited by 53
Self-citationCharacterization of seven novel mutations in seven patients with GAMT deficiency: MUTATIONS IN BRIEF
Item, C. B., Mercimek-Mahmutoglu, S., Battini, R., Edlinger-Horvat, C., Stromberger, C., Bodamer, O., Mühl, A., Vilaseca, M. A., Korall, H., & Stöckler-Ipsiroglu, S. (2004) · Human Mutation · doi:10.1002/humu.9238 · Cited by 50
Self-citationTherapeutic trial of arginine restriction in creatine deficiency syndrome
Schulze, A., Mayatepek, E., Bachert, P., Marescau, B., Deyn, P. P. D., & Rating, D. (1998) · European Journal of Pediatrics · doi:10.1007/s004310050890 · Cited by 39
Item, C. B., Stromberger, C., Mühl, A., Edlinger-Horvat, C., Bodamer, O. A., Schulze, A., Surtees, R. A. H., Leuzzi, V., Salomons, G. S., Jakobs, C., et al. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.5.767 · Cited by 19
Self-citationDisorders of Creatine Metabolism
Stöckler‐Ipsiroglu, S., Battini, R., DeGrauw, T., & Schulze, A. (2006) · Springer eBooks · doi:10.1007/3-540-28962-3_26 · Cited by 17
Self-citation
Research works printed but not linked: 2
- Item CB, Stöckler-Ipsiroglu S, Stromberger C et al. (2001) Arginine:glycine amidino- transferase (AGAT) deficiency: the third in- born error of creatine metabolism in hu- mans. Am J Hum Genet.; 69: 1127-33.
- Item CB, Mercimek-Mahmutoglu S, Battini R et al. (2004) Characterisation of seven novel mutations in seven patients with GAMT defi- ciency. Hum Mutat.; 23: 524.
Cited by
MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription
Chahrour, M., Jung, S. Y., Shaw, C., Zhou, X., Wong, S. T. C., Qin, J., & Zoghbi, H. Y. (2008) · Science · doi:10.1126/science.1153252 · Cited by 1,823
Kreider, R. B., Kalman, D. S., Antonio, J., Ziegenfuss, T. N., Wildman, R., Collins, R., Candow, D. G., Kleiner, S. M., Almada, A. L., & Lopez, H. L. (2017) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-017-0173-z · Cited by 1,057
“As a result, they often have clinical manifestations of muscle myopathies, gyrate atrophy, movement disorders, speech delay, autism, mental retardation, epilepsy, and/or developmental problems [13, 17, 145].”
BackgroundFunctions and effects of creatine in the central nervous system
Andres, R. H., Ducray, A. D., Schlattner, U., Wallimann, T., & Widmer, H. R. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.02.035 · Cited by 368
Creatine: Endogenous Metabolite, Dietary, and Therapeutic Supplement
Brosnan, J. T., & Brosnan, M. E. (2007) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.27.061406.093621 · Cited by 347
Creatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
Metadata
- Authors
- Sykut-Cegielska, J., Gradowska, W., Mercimek-Mahmutoglu, S., & Stöckler-Ipsiroglu, S.
- Affiliations
- University of Vienna (AT)
- Venue
- Acta Biochimica Polonica
- Publisher
- Frontiers Media SA
- Published
- 2004-12-31
- Volume
- 51
- Issue
- 4
- Pages
- 875-882
- ISSN
- 0001-527X (ISSN-L)
- 1734-154X
- OpenAlex
- W2067360430
- Cited by
- 60
- References
- 20
- Citations by year
- 2025: 1 · 2022: 3 · 2021: 3 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 1 · 2014: 3 · 2013: 3 · 2012: 3
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-sa
- Locations
- Acta Biochimica Polonica (publishedVersion, cc-by-sa)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- creatine deficiency syndrome, guanidinoacetate methyltransferase deficiency, creatine transporter deficiency, guanidinoacetic acid, intellectual disability, epilepsy, creatine supplementation, 1H NMR, underdiagnosis
- MeSH terms
- Amidinotransferases, Amino Acid Metabolism, Inborn Errors, Creatine, Humans, Methyltransferases, Membrane Transport Proteins, Guanidinoacetate N-Methyltransferase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.